NewsFeed
November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Khalil Faaed: Beyond ROS – The Antioxidant Revolution in IVF
Oct 31, 2026, 17:52

Khalil Faaed: Beyond ROS – The Antioxidant Revolution in IVF

Khalil Faaed, Embryologist at Modern IVF Center, shared on LinkedIn:

“Beyond ROS: The Antioxidant Revolution in IVF: Can Redox Optimization Improve Fertilization and Blastocyst Development?

Can modifying the oxidative environment of the IVF laboratory improve fertilization outcomes?

A fascinating randomized controlled trial published in Human Reproduction (2025) provides new insights into the potential role of antioxidant-enriched culture media in assisted reproductive technology.

The study, involving 1,482 patients, investigated whether incorporating three antioxidants into IVF laboratory media could improve fertilization and subsequent embryonic development.

What Did the Researchers Discover?

The findings were particularly interesting:

1. Improved fertilization rate

The fertilization rate increased from 59.2% in the control group to 64.5% in the antioxidant group.

2. A remarkable finding in ICSI cycles

ICSI fertilization increased from 57.9% to 68.3% with antioxidant-enriched media.

Additionally, cycles with failed fertilization decreased from 8.0% to 3.7%.

3. Increased blastocyst availability

The mean number of utilized blastocysts per patient increased from 2.70 to 3.09.

However, the blastocyst development rate per fertilized oocyte and the proportion of good-quality blastocysts did not significantly improve. But٫ Did improved fertilization translate into better pregnancy outcomes?

Not in this trial.

The researchers found no statistically significant improvement in clinical pregnancy following fresh blastocyst transfer or live birth rates.

This distinction is essential: improving laboratory performance does not automatically translate into improved reproductive outcomes.

What Does This Mean for Clinical Embryologists?

This research highlights the importance of redox homeostasis in the IVF laboratory.

Rather than considering ROS exclusively as harmful molecules, we should recognize that physiological ROS participate in important cellular signalling pathways. The objective is not to eliminate ROS, but to maintain an appropriate balance between oxidative activity and antioxidant defence.

It also raises important questions:

  • Could antioxidant supplementation have a greater impact in patients with increased oxidative stress?
  • Why was the improvement observed in ICSI but not conventional IVF?
  • Could different antioxidant concentrations influence oocyte competence and fertilization?
  • Will future studies demonstrate an improvement in cumulative live birth rates?

The future of embryo culture may involve more than providing essential nutrients and maintaining optimal physical conditions. Understanding and optimizing the biochemical environment, including redox balance, could become another important aspect of IVF laboratory development.

However, robust evidence of improved clinical outcomes must remain the ultimate standard.”

Other articles featuring Khalil Faaed on Fertility News.